德展健康(000813) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥111,144,059.87, representing a 4.70% increase year-over-year, but a 21.71% decrease for the year-to-date period[5]. - The net profit attributable to shareholders was -¥18,098,873.86, a significant decline of 777.27% compared to the same period last year, and a year-to-date decline of 854.37% to -¥61,025,357.03[5]. - The basic and diluted earnings per share were both -¥0.0085, reflecting a decrease of 750.00% year-over-year and 878.38% year-to-date[5]. - Total operating revenue for the current period is ¥277,500,292.60, down 21.7% from ¥354,472,693.30 in the previous period[25]. - Net profit for the current period is a loss of ¥88,537,198.97, compared to a loss of ¥8,329,156.02 in the previous period, indicating a significant decline in profitability[26]. - The company reported a basic and diluted earnings per share of -0.0288, compared to 0.0037 in the previous period[27]. Assets and Liabilities - The total assets at the end of Q3 2025 were ¥5,233,330,047.52, down 1.63% from the end of the previous year[5]. - As of September 30, 2025, the total assets of the company amounted to ¥5,233,330,047.52, a decrease from ¥5,319,833,620.49 at the beginning of the period[20]. - The company's cash and cash equivalents decreased to ¥2,365,526,990.47 from ¥2,530,699,274.17, reflecting a decline of approximately 6.5%[20]. - Total liabilities increased to ¥271,088,648.98 from ¥154,884,054.36, reflecting a significant rise in financial obligations[22]. - Non-current liabilities rose sharply to ¥160,404,041.83 from ¥45,010,236.25, indicating increased long-term financial commitments[22]. - The company's total equity decreased to ¥4,962,241,398.54 from ¥5,164,949,566.13, showing a decline in shareholder value[23]. Cash Flow - Cash flow from operating activities for the year-to-date period was ¥26,411,149.81, showing a substantial increase of 205.30%[5]. - The net cash flow from operating activities was $26,411,149.81, a significant improvement compared to a net outflow of -$25,080,901.14 in the previous period, indicating a turnaround in operational performance[30]. - The net cash flow from investing activities was -$191,552,325.58, worsening from -$110,143,377.46 in the prior period, reflecting increased investment expenditures[31]. - Cash and cash equivalents at the end of the period totaled $2,275,231,169.90, down from $2,531,158,919.42 at the end of the previous period, showing a decrease of approximately 10%[31]. - The total cash inflow from financing activities was $118,800,000.00, with cash outflow totaling $136,006,267.42, resulting in a net cash outflow of -$17,206,267.42[31]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 57,596[14]. - Xinjiang Kaidi Investment Co., Ltd. holds 19.54% of shares, totaling 409,748,445 shares, with 143,000,000 shares pledged[14]. - The top 10 shareholders include Meilin Holdings Group Co., Ltd. with 8.85% (185,672,150 shares) and Chen Zhiwenlong with 6.18% (129,500,000 shares)[14]. - Xinjiang Kaidi Mining Investment Co., Ltd. holds 4.96% (104,039,367 shares) and Zhu Ming holds 4.01% (84,073,700 shares)[15]. - The total shares held by the top 10 unrestricted shareholders amount to 409,748,445 shares[15]. - The company has not reported any changes in the top 10 shareholders due to margin trading or lending of shares[15]. Investments and Expenses - Investment losses increased by 37.58% to -¥13,980,876.41, mainly due to higher losses from investments in joint ventures[11]. - Research and development expenses decreased to ¥29,070,328.37 from ¥36,148,711.02, a reduction of 19.5%[26]. - The company reported a significant investment loss of ¥13,980,876.41, compared to a loss of ¥10,162,176.84 in the previous period[26]. - The company’s cash flow from investment activities reflects a strategic focus on growth, with substantial investments in fixed assets totaling $156,921,325.46[30]. Corporate Governance - The company plans to hold a board meeting to elect a new chairman and senior management, indicating a potential shift in governance[18]. - The company established a "Technology Innovation Development Center" to enhance its technological innovation capabilities and decision-making processes[18]. - The company has completed the cancellation of repurchased shares, aligning with legal regulations regarding share buybacks[20].